We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA Supports Biosimilars, Comparative Effectiveness to Cut Costs
PhRMA Supports Biosimilars, Comparative Effectiveness to Cut Costs
June 2, 2009
As part of President Barack Obama’s effort to trim $2 trillion in U.S. healthcare spending, PhRMA has offered solutions including the development of a biosimilars approval pathway.